Follow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles Tendinopathy

Introduction: Achilles tendinopathy can be a chronic disabling condition. Sclerosing injections under ultrasonographic guidance is one method to treat Achilles tendinopathy. Initially good results have later been questioned. Surgery is another treatment option that has been questioned because of var...

Full description

Bibliographic Details
Main Author: Hammar Clausen, Adrian
Format: Others
Language:English
Published: Örebro universitet, Institutionen för medicinska vetenskaper 2019
Subjects:
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-72993
id ndltd-UPSALLA1-oai-DiVA.org-oru-72993
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-oru-729932019-03-08T05:55:54ZFollow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles TendinopathyengHammar Clausen, AdrianÖrebro universitet, Institutionen för medicinska vetenskaper2019Achilles tendinopathyConservative treatmentPhysiotherapySclerosing injectionsSelf-reported foot and ankle scoreMedical and Health SciencesMedicin och hälsovetenskapIntroduction: Achilles tendinopathy can be a chronic disabling condition. Sclerosing injections under ultrasonographic guidance is one method to treat Achilles tendinopathy. Initially good results have later been questioned. Surgery is another treatment option that has been questioned because of varying reported success rate. Aim: We aimed to assess patient- reported outcome in patients suffering from Achilles tendinopathy, treated with sclerosing injections and/or surgery during a 6 ½ year- period. Method: After review of patient records, the Self-reported foot and ankle score (SEFAS) together with an in-house satisfaction questionnaire were mailed to the patients. A SEFAS score of 48 represents normal foot/ankle function. Results: 97 patients (53 women, 44 men, 104 tendons) were included. 69 patients (41 women, 28 men, 75 tendons) returned the questionnaires. The SEFAS values (median and range) were 37.5 (13-48) in patients treated with sclerosing therapy, 42 (15-48) in patients treated surgically and 47 (19-48) in patients that received both treatments. A greater proportion of surgically treated patients were satisfied (90% vs 50%), experienced symptom improvement and were able to return to the previous level of activity. Complications following surgery were wound infections (n=3) and deep vein thrombosis (n=3), two with pulmonary embolism. Following sclerosing injection, there was one complete Achilles tendon rupture. Conclusion: Sclerosing injections seems to be a safe treatment and a positive outcome in 50% of patients might be sufficient to use this therapy in selected patients with Achilles tendinopathy. However, surgical treatments seem more effective but are associated with more severe complications. Student thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-72993application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Others
sources NDLTD
topic Achilles tendinopathy
Conservative treatment
Physiotherapy
Sclerosing injections
Self-reported foot and ankle score
Medical and Health Sciences
Medicin och hälsovetenskap
spellingShingle Achilles tendinopathy
Conservative treatment
Physiotherapy
Sclerosing injections
Self-reported foot and ankle score
Medical and Health Sciences
Medicin och hälsovetenskap
Hammar Clausen, Adrian
Follow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles Tendinopathy
description Introduction: Achilles tendinopathy can be a chronic disabling condition. Sclerosing injections under ultrasonographic guidance is one method to treat Achilles tendinopathy. Initially good results have later been questioned. Surgery is another treatment option that has been questioned because of varying reported success rate. Aim: We aimed to assess patient- reported outcome in patients suffering from Achilles tendinopathy, treated with sclerosing injections and/or surgery during a 6 ½ year- period. Method: After review of patient records, the Self-reported foot and ankle score (SEFAS) together with an in-house satisfaction questionnaire were mailed to the patients. A SEFAS score of 48 represents normal foot/ankle function. Results: 97 patients (53 women, 44 men, 104 tendons) were included. 69 patients (41 women, 28 men, 75 tendons) returned the questionnaires. The SEFAS values (median and range) were 37.5 (13-48) in patients treated with sclerosing therapy, 42 (15-48) in patients treated surgically and 47 (19-48) in patients that received both treatments. A greater proportion of surgically treated patients were satisfied (90% vs 50%), experienced symptom improvement and were able to return to the previous level of activity. Complications following surgery were wound infections (n=3) and deep vein thrombosis (n=3), two with pulmonary embolism. Following sclerosing injection, there was one complete Achilles tendon rupture. Conclusion: Sclerosing injections seems to be a safe treatment and a positive outcome in 50% of patients might be sufficient to use this therapy in selected patients with Achilles tendinopathy. However, surgical treatments seem more effective but are associated with more severe complications.
author Hammar Clausen, Adrian
author_facet Hammar Clausen, Adrian
author_sort Hammar Clausen, Adrian
title Follow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles Tendinopathy
title_short Follow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles Tendinopathy
title_full Follow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles Tendinopathy
title_fullStr Follow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles Tendinopathy
title_full_unstemmed Follow-up of Patients Treated with Sclerosing Therapy and/or Surgery for Achilles Tendinopathy
title_sort follow-up of patients treated with sclerosing therapy and/or surgery for achilles tendinopathy
publisher Örebro universitet, Institutionen för medicinska vetenskaper
publishDate 2019
url http://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-72993
work_keys_str_mv AT hammarclausenadrian followupofpatientstreatedwithsclerosingtherapyandorsurgeryforachillestendinopathy
_version_ 1719000445236543488